Related Experiment Video
Updated: Jul 6, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
[Dementia. Most frequent forms of beginning]
Raúl L Arizaga1, Diana O Cristalli, Angel Golimstok
1Consortium Argentino para el Estudio de la Demencia.
Vertex (Buenos Aires, Argentina)
|April 9, 2008
Summary
This chapter details common dementia symptom onset patterns for Alzheimer's, Lewy body, vascular, and frontotemporal dementia. Early clinical presentation can be atypical, making initial dementia diagnosis challenging.
Area of Science:
- Neurology
- Neuroscience
- Geriatrics
Context:
- Presents findings from the Argentine Consortium for Dementia Study (CAED).
- Focuses on the initial clinical presentation of common dementia types.
- Highlights the challenges in early dementia diagnosis.
Purpose:
- To describe the most frequent initial symptoms for Alzheimer's disease, dementia with Lewy bodies, vascular dementia, and frontotemporal dementia.
- To emphasize the frequent discrepancy between initial clinical impressions and definitive etiological diagnoses.
- To inform clinicians and families about the complexities of early dementia diagnosis.
Summary:
- Details common onset patterns for four prevalent dementias: Alzheimer's, Lewy body, vascular, and frontotemporal.
- Notes that initial symptoms are often atypical, leading to diagnostic uncertainty.
- Explains that early impressions may differ from the final diagnosis based on disease progression.
Impact:
- Aids in understanding the variability of dementia symptom presentation.
- Improves awareness of diagnostic challenges in early-stage dementia.
- Supports more accurate initial assessments and patient/family counseling regarding dementia diagnosis.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...